Direct-acting antiviral treatment outcomes in people infected with endemic compared to epidemic hepatitis C virus subtypes in England
This study provides further evidence that endemic HCV subtypes lead to sub-optimal DAA efficacy, which may impact global HCV elimination.
Authors
- Daniel Bradshaw (ORCID: https://orcid.org/0000-0001-7186-2482)
- Jean L. Mbisa (ORCID: https://orcid.org/0000-0002-0348-9679)
- Simon Packer (ORCID: https://orcid.org/0000-0002-9157-3650)
- Laura Phillips (ORCID: https://orcid.org/0000-0002-6453-0129)
- Caroline Anne Sabin (ORCID: https://orcid.org/0000-0001-5173-2760)
- William Rosenberg (ORCID: https://orcid.org/0000-0002-2732-2304)
- Ruth Simmons (ORCID: https://orcid.org/0000-0001-8156-0146)
Institutions
- The Royal Free Hospital (GB)
- National Institute for Health and Care Research (GB)
- UK Health Security Agency (GB)
- University College London (GB)
Publication Details
- Journal
- Journal of Infection
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1016/j.jinf.2025.106465
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64